Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2013 | 06-2012 | 06-2011 | 06-2010 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 4,167 | N/A | N/A | N/A | N/A |
| Accounts receivable | -9,456 | -1,827 | -12,408 | -3,833 | -593 |
| Other Working Capital | -3,855 | -7,111 | -9,072 | -3,438 | 375 |
| Other Operating Activity | 46,009 | 28,180 | 38,234 | 24,595 | 20,552 |
| Operating Cash Flow | $36,865 | $19,242 | $16,754 | $17,324 | $20,334 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,654 | -1,595 | -4,088 | -2,721 | -3,634 |
| Net Acquisitions | -10,333 | -112,221 | -33,047 | N/A | N/A |
| Purchase Sale Intangibles | -3,871 | -6,747 | N/A | N/A | N/A |
| Other Investing Activity | -1,510 | 219 | 957 | 1,006 | 2,145 |
| Investing Cash Flow | $-19,368 | $-120,344 | $-36,178 | $-1,715 | $-1,489 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 120,000 | 68,000 | N/A | N/A |
| Debt Repayment | -7,942 | -66,928 | -42,773 | -5,671 | -9,131 |
| Common Stock Issued | 846 | 60,575 | 541 | 589 | 288 |
| Dividend Paid | -11,170 | -8,325 | -7,221 | -6,195 | -5,565 |
| Other Financing Activity | 0 | -1,614 | 320 | 456 | 0 |
| Financing Cash Flow | $-18,266 | $103,708 | $18,867 | $-10,821 | $-14,408 |
| Exchange Rate Effect | 1,125 | -667 | -449 | -103 | 161 |
| Beginning Cash Position | 32,435 | 30,496 | -6,701 | -15,527 | -26,997 |
| End Cash Position | 32,791 | 32,435 | -34,091 | -6,701 | -15,527 |
| Net Cash Flow | $-769 | $2,606 | $-557 | $4,788 | $4,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,865 | 19,242 | 16,754 | 17,324 | 20,334 |
| Capital Expenditure | -9,120 | -8,392 | -4,090 | -2,721 | -3,676 |
| Free Cash Flow | 27,745 | 10,850 | 12,664 | 14,603 | 16,658 |